Fisher & Paykel Healthcare (ASX:FPH) Change In Inventory: A$0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:FPH Fisher & Paykel Healthcare Corp Ltd ASX:FPH
89 GF Score
Price A$32.83
GF Value A$36.55
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Fisher & Paykel Healthcare Change In Inventory?

Fisher & Paykel Healthcare ASX:FPH -0.76% 89 Change In Inventory is A$0 Mil as of Mar. 2026. GuruFocus rates ASX:FPH with a GF Score™ of 89/100 and a GF Value™ of A$36.55 (Modestly Undervalued). The stock has 2 warning signs investors should review.

Fisher & Paykel Healthcare's change in inventory for the quarter that ended in Mar. 2026 was A$0 Mil. It means Fisher & Paykel Healthcare's inventory stayed the same from Sep. 2025 to Mar. 2026 .

Fisher & Paykel Healthcare's change in inventory for the fiscal year that ended in Mar. 2026 was A$0 Mil. It means Fisher & Paykel Healthcare's inventory stayed the same from Mar. 2025 to Mar. 2026 .

Fisher & Paykel Healthcare's Total Inventories for the quarter that ended in Mar. 2026 was A$273 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Fisher & Paykel Healthcare's Days Inventory for the quarter that ended in Mar. 2026 was 144.12.

Inventory Turnover measures how fast the company turns over its inventory within a year. Fisher & Paykel Healthcare's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.27.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Fisher & Paykel Healthcare's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.28.

Fisher & Paykel Healthcare  (ASX:FPH) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Fisher & Paykel Healthcare's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=286.593/362.917*365 / 2
=144.12

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Fisher & Paykel Healthcare's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=362.917 / 286.593
=1.27

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Fisher & Paykel Healthcare's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=286.593 / 1006.5
=0.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Change In Inventory Related Terms

Fisher & Paykel Healthcare Change In Inventory Historical Data

* Premium members only.

The historical data trend for Fisher & Paykel Healthcare's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fisher & Paykel Healthcare Change In Inventory Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Fisher & Paykel Healthcare Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ASX:FPH
89GF Score
Fisher & Paykel Healthcare Corp Ltd ASX:FPH
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Fisher & Paykel Healthcare Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of A$0 Mil mean?
Fisher & Paykel Healthcare (ASX:FPH) has a Change In Inventory of A$0 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Fisher & Paykel Healthcare and its competitors.
Is Fisher & Paykel Healthcare's Change In Inventory too high?
Fisher & Paykel Healthcare's current Change In Inventory is A$0 Mil. Overall, Fisher & Paykel Healthcare has a GF Score™ of 89/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Fisher & Paykel Healthcare's Change In Inventory compare to ISRG and BDX?
Fisher & Paykel Healthcare's Change In Inventory of A$0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Devices & Instruments company?
A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Fisher & Paykel Healthcare and its competitors. Fisher & Paykel Healthcare's current Change In Inventory is A$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fisher & Paykel Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Fisher & Paykel Healthcare (ASX:FPH) is currently considered Modestly Undervalued. The stock's GF Value™ is A$36.55, compared to a current price of A$32.83 — trading 10.2% below its estimated fair value. The current Change In Inventory is A$0 Mil. Fisher & Paykel Healthcare's overall GF Score™ is 89/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Fisher & Paykel Healthcare (ASX:FPH), the current Change In Inventory is A$0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Fisher & Paykel Healthcare (ASX:FPH) Overvalued in 2026?

Based on GuruFocus' analysis, Fisher & Paykel Healthcare stock appears to be undervalued. The current stock price of A$32.83 is trading 10.2% below its estimated GF Value™ of A$36.55. GuruFocus considers Fisher & Paykel Healthcare to be Modestly Undervalued.

Key valuation signals for ASX:FPH:

  • Change In Inventory: A$0 Mil
  • GF Value™: A$36.55 vs. price of A$32.83 (10.2% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the ASX:FPH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fisher & Paykel Healthcare Business Description

Other Exchanges FSPKF:USAFPH:New Zealand
Address 15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use of humidifiers, masks, and related consumables, and the number three player in the at-home treatment of sleep apnea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns roughly half of its revenue in North America, around a quarter in Europe, and approximately a fifth in Asia-Pacific. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand, Mexico, and China, and has a multichannel distribution model.
89GF Score

Get the complete analysis for ASX:FPH

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$32.83
Price
A$36.55
GF Value